AiViva BioPharma, Inc.
AiViva BioPharma, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration | eye disorder, macular degeneration, retinal degeneration, retinal disorder | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07557121 | |
| Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) | diabetic macular edema, eye disorder, macular degeneration, macular retinal edema, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 | 2025-03-06 | NCT05698329 |